Bayer Kogenate FS
Bayer HealthCare, Biological Products Division

Contact Search Press Sitemap  
HomePatients & CaregiversHealthcare ProfessionalsPrescribing Information
Kogenate FS
Prescribing Information
Important Safety Information
Patient Video
EZ-Log
Bayer Factor Solutions
Kogenate Connections
Summer Camps
Hemophilia Awards
PEP
Rep Finder
Living with Hemophilia
Bayer Links
Bayer Global
Living with Hemophilia
   General Conditions of Use
Privacy Statement
Imprint
  
 
  

Join Bayer's Mailing List

Please be assured that personal information submitted in this form will be kept confidential. For more on Bayer's privacy policy, please read our Privacy Statement before providing your personal information.

If you are 13 years of age or under, please ask your parent or legal guardian to complete this form.

Help us meet your needs by answering the following questions:

*Name:
*Specialty:
Institution:
*Email Address:
*Address:
*City:
*State:
*Postal Code:
Country:
*Phone:
Interests: Please email me updates on Bayer's programs, services, and news
Please e-mail me when there is new information on the site
 

Do not use the contact information on this Web site for medical emergencies. For medical emergencies dial 911, or contact your healthcare professional.

For medical and technical information or to report an adverse drug event involving a Bayer HealthCare product, please contact Bayer's Medical Communications at 1-888-84-BAYER (1-888-842-2937).

For customer service, contact Bayer HealthCare USA Customer Service during regular business hours, 8:00 AM - 5:00 PM Eastern Standard Time, at (888) 606-3780.

Should you wish to unsubscribe at any time, please contact us and indicate that you would like to be removed from our mailing list.

International legal and regulatory directives prohibit us from responding to patients and family members living outside the United States. If you reside outside the US and have a question, please speak with your physician or healthcare provider.



  

Kogenate® FS, Antihemophilic Factor (Recombinant), is a recombinant factor VIII treatment indicated for the treatment of hemophilia A. The most frequently reported adverse events were local injection site reactions, dizziness, and rash. Known intolerance or allergic reactions to constituents of the preparation is a contraindication to the use of Kogenate® FS. Known hypersensitivity to mouse or hamster protein may be a contraindication to the use of Kogenate® FS. For important safety and use information, please see the full prescribing information.

Please consult your health care provider prior to making any lifestyle changes. The images used on this site do not necessarily represent actual Hemophilia patients.